|
| Article Authors: | Deepa Trivedi; Roxanne Y Williams; Richard J O'Reilly; Guenther Koehne |
|---|
| Article Title: | Generation of CMV-specific T lymphocytes using protein-spanning pools of pp65-derived overlapping pentadecapeptides for adoptive immunotherapy. |
|---|
|
| Reference ID: | 618 |
|---|
| Abstract: | Cell-mediated immunity is essential for control of human cytomegalovirus (HCMV) infection. We used a pool of 138 synthetic overlapping pentadecapeptides overspanning the entire pp65 protein to generate polyclonal CMV-specific T-cell lines from 12 CMV-seropositive donors inheriting different HLA genotypes. Autologous monocyte-derived dendritic cells (DCs) pulsed with this complete pool consistently induced highly specific T cells that selectively recognized 1-3 pentadecapeptides identified by secondary responses to a mapping grid of pentadecapeptide subpools with single overlaps. Responses against peptide-loaded targets sharing single HLA class I or II alleles identified the restricting HLA alleles. HLA-A*0201+ donors consistently responded to pentadecapeptides containing HLA-A*0201-binding epitope(aa495-503)NLVPMVATV. T-cell lines from other donors contained high frequencies of CD4 and/or CD8 T cells selectively reactive against peptides presented by other HLA alleles, including both known epitopes such as (aa341-350)QYDPVAALF (HLA-A*2402) as well as unreported epitopes such as (aa267-275)HERNGFTVL (HLA-B*4001 and B*4002) and (aa513-523)FFWDANDIYRI (HLA-DRB1*1301). These T cells consistently lysed CMV-infected target cells. Thus, this approach fosters expansion and selection of HLA-restricted CMV-pp65-reactive T-cell lines of high specificity that also lyse CMV-infected targets, and from a functional and regulatory perspective, may have advantages for generating virus-specific T cells for adoptive immunotherapy. |
|---|
| Affiliations: | Allogenic Bone Marrow Transplantation Service, Department of Pediatrics, Transplantation Biology Laboratory, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. |
|---|
| Date: | 2005 |
|---|
| Reference Type: | Literature |
|---|
| PubMed ID: | 15514011 |
|---|
| Journal: | Blood |
|---|
| Journal Volume: | 105 |
|---|
| Article Pages: | 2793-801 |
|---|
| Journal ISSN: | 1528-0020 |
|---|
| Article Chemical List: | Epitopes, T-Lymphocyte;Histocompatibility Antigens Class II;Phosphoproteins;Viral Matrix Proteins;cytomegalovirus matrix protein 65kDa |
|---|
| Article MeSH List: | Amino Acid Sequence; CD4-Positive T-Lymphocytes(immunology; virology); Cell Line; Cytomegalovirus Infections(immunology; therapy); Epitopes, T-Lymphocyte(immunology); Fibroblasts(cytology); Genotype; Histocompatibility Antigens Class II(genetics; immunology); Humans; Immunotherapy, Adoptive(methods); Molecular Sequence Data; Phosphoproteins(genetics; immunology); Viral Matrix Proteins(genetics; immunology) |
|---|
| Curation Last Updated: | 2013-03-21 20:01:14 |
|---|